Pfizer (NYSE:PFE) hit a new 52-week high Thursday as it is currently trading at $26.89, above its previous 52-week high of $26.88 with 19.6 million shares traded as of 2:21 p.m. ET. Average volume has been 30.7 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Pfizer (NYSE: PFE) hit a new 52-week high Thursday as it is currently trading at $26.89, above its previous 52-week high of $26.88 with 19.6 million shares traded as of 2:21 p.m. ET. Average volume has been 30.7 million shares over the past 30 days. Pfizer has a market cap of $195.99 billion and is part of the health care sector and drugs industry. Shares are up 6.1% year to date as of the close of trading on Wednesday. Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide. The company has a P/E ratio of 20.6, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Pfizer Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.